ID EDEM3_MOUSE Reviewed; 931 AA. AC Q2HXL6; B2RS10; B9EHZ4; Q6P9L0; DT 05-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 03-MAR-2009, sequence version 2. DT 27-MAR-2024, entry version 131. DE RecName: Full=ER degradation-enhancing alpha-mannosidase-like protein 3; DE EC=3.2.1.113 {ECO:0000250|UniProtKB:P32906}; DE AltName: Full=Alpha-1,2-mannosidase EDEM3; DE Flags: Precursor; GN Name=Edem3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE RP SPECIFICITY, INDUCTION, AND MUTAGENESIS OF GLU-147. RX PubMed=16431915; DOI=10.1074/jbc.m512191200; RA Hirao K., Natsuka Y., Tamura T., Wada I., Morito D., Natsuka S., Romero P., RA Sleno B., Tremblay L.O., Herscovics A., Nagata K., Hosokawa N.; RT "EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic RT reticulum-associated degradation and mannose trimming."; RL J. Biol. Chem. 281:9650-9658(2006). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain, Embryonic brain, and Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP REVIEW. RX PubMed=17499246; DOI=10.1016/j.febslet.2007.04.070; RA Olivari S., Molinari M.; RT "Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation RT of folding-defective glycoproteins."; RL FEBS Lett. 581:3658-3664(2007). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brown adipose tissue, Liver, Lung, Pancreas, Spleen, and RC Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [5] RP DISRUPTION PHENOTYPE, AND FUNCTION. RX PubMed=34143952; DOI=10.1016/j.ajhg.2021.05.010; RA Polla D.L., Edmondson A.C., Duvet S., March M.E., Sousa A.B., Lehman A., RA Niyazov D., van Dijk F., Demirdas S., van Slegtenhorst M.A., Kievit A.J.A., RA Schulz C., Armstrong L., Bi X., Rader D.J., Izumi K., Zackai E.H., RA de Franco E., Jorge P., Huffels S.C., Hommersom M., Ellard S., RA Lefeber D.J., Santani A., Hand N.J., van Bokhoven H., He M., RA de Brouwer A.P.M.; RT "Bi-allelic variants in the ER quality-control mannosidase gene EDEM3 cause RT a congenital disorder of glycosylation."; RL Am. J. Hum. Genet. 108:1342-1349(2021). CC -!- FUNCTION: Involved in endoplasmic reticulum-associated degradation CC (ERAD). Accelerates the glycoprotein ERAD by proteasomes, by catalyzing CC mannose trimming from Man8GlcNAc2 to Man7GlcNAc2 in the N-glycans. May CC also participate in mannose trimming from all glycoproteins and not CC just misfolded ones targeted to ERAD (PubMed:34143952). May have alpha CC 1,2-mannosidase activity. {ECO:0000250|UniProtKB:Q9BZQ6, CC ECO:0000269|PubMed:16431915, ECO:0000269|PubMed:34143952}. CC -!- CATALYTIC ACTIVITY: CC Reaction=4 H2O + N(4)-(alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D- CC Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man- CC (1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)- CC beta-D-GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] (N-glucan CC mannose isomer 9A1,2,3B1,2,3) = 4 beta-D-mannose + N(4)-(alpha-D-Man- CC (1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]- CC beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl- CC [protein] (N-glucan mannose isomer 5A1,2); Xref=Rhea:RHEA:56008, CC Rhea:RHEA-COMP:14356, Rhea:RHEA-COMP:14367, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:28563, ChEBI:CHEBI:59087, ChEBI:CHEBI:139493; CC EC=3.2.1.113; Evidence={ECO:0000250|UniProtKB:P32906}; CC -!- CATALYTIC ACTIVITY: CC Reaction=3 H2O + N(4)-(alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D- CC Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man- CC (1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)- CC beta-D-GlcNAc)-L-asparaginyl-[protein] (N-glucan mannose isomer CC 8A1,2,3B1,3) = 3 beta-D-mannose + N(4)-(alpha-D-Man-(1->3)-[alpha-D- CC Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man- CC (1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc)-L-asparaginyl-[protein] CC (N-glucan mannose isomer 5A1,2); Xref=Rhea:RHEA:56028, Rhea:RHEA- CC COMP:14358, Rhea:RHEA-COMP:14367, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:28563, ChEBI:CHEBI:59087, ChEBI:CHEBI:60628; CC EC=3.2.1.113; Evidence={ECO:0000250|UniProtKB:P32906}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC Evidence={ECO:0000250|UniProtKB:P45700}; CC -!- PATHWAY: Protein modification; protein glycosylation. CC {ECO:0000250|UniProtKB:P32906}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000255|PROSITE- CC ProRule:PRU10138, ECO:0000269|PubMed:16431915}. CC -!- TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in CC liver, heart and kidney. {ECO:0000269|PubMed:16431915}. CC -!- INDUCTION: Slightly increased by endoplasmic reticulum stress. CC {ECO:0000269|PubMed:16431915}. CC -!- DOMAIN: Contains a protease-associated domain of unknown function. CC -!- PTM: N-glycosylated. CC -!- DISRUPTION PHENOTYPE: The knockout mice show largely skewed ratios of CC homozygous knockout pups versus heterozygous and wild-type pups. CC However knockout animals do not present with any obvious phenotype, CC only subtle changes, such as reduced weight of brains and body, as well CC as significantly increased abundance of circulating Man8GlcNAc2 and CC Man9GlcNAc2 in the plasma. {ECO:0000269|PubMed:34143952}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 47 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB188342; BAE79485.1; -; mRNA. DR EMBL; BC060718; AAH60718.1; -; mRNA. DR EMBL; BC138658; AAI38659.1; -; mRNA. DR EMBL; BC138659; AAI38660.1; -; mRNA. DR CCDS; CCDS35736.1; -. DR RefSeq; NP_001034733.2; NM_001039644.2. DR AlphaFoldDB; Q2HXL6; -. DR SMR; Q2HXL6; -. DR BioGRID; 211842; 8. DR IntAct; Q2HXL6; 6. DR STRING; 10090.ENSMUSP00000058941; -. DR CAZy; GH47; Glycoside Hydrolase Family 47. DR GlyConnect; 2299; 1 N-Linked glycan (1 site). DR GlyCosmos; Q2HXL6; 7 sites, 1 glycan. DR GlyGen; Q2HXL6; 7 sites, 1 N-linked glycan (1 site). DR iPTMnet; Q2HXL6; -. DR PhosphoSitePlus; Q2HXL6; -. DR EPD; Q2HXL6; -. DR MaxQB; Q2HXL6; -. DR PaxDb; 10090-ENSMUSP00000058941; -. DR PeptideAtlas; Q2HXL6; -. DR ProteomicsDB; 277679; -. DR Pumba; Q2HXL6; -. DR Antibodypedia; 20607; 146 antibodies from 25 providers. DR Ensembl; ENSMUST00000059498.12; ENSMUSP00000058941.6; ENSMUSG00000043019.13. DR GeneID; 66967; -. DR KEGG; mmu:66967; -. DR UCSC; uc007czc.2; mouse. DR AGR; MGI:1914217; -. DR CTD; 80267; -. DR MGI; MGI:1914217; Edem3. DR VEuPathDB; HostDB:ENSMUSG00000043019; -. DR eggNOG; KOG2430; Eukaryota. DR GeneTree; ENSGT00940000159391; -. DR InParanoid; Q2HXL6; -. DR OrthoDB; 942598at2759; -. DR PhylomeDB; Q2HXL6; -. DR TreeFam; TF300807; -. DR BRENDA; 3.2.1.209; 3474. DR UniPathway; UPA00378; -. DR BioGRID-ORCS; 66967; 4 hits in 78 CRISPR screens. DR ChiTaRS; Edem3; mouse. DR PRO; PR:Q2HXL6; -. DR Proteomes; UP000000589; Chromosome 1. DR RNAct; Q2HXL6; Protein. DR Bgee; ENSMUSG00000043019; Expressed in lacrimal gland and 259 other cell types or tissues. DR ExpressionAtlas; Q2HXL6; baseline and differential. DR GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central. DR GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:MGI. DR GO; GO:0016020; C:membrane; IEA:InterPro. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; IDA:MGI. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR GO; GO:0036503; P:ERAD pathway; IDA:ParkinsonsUK-UCL. DR GO; GO:0006516; P:glycoprotein catabolic process; IDA:MGI. DR GO; GO:0006058; P:mannoprotein catabolic process; IDA:ParkinsonsUK-UCL. DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:MGI. DR GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway. DR GO; GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW. DR CDD; cd02126; PA_EDEM3_like; 1. DR Gene3D; 1.50.10.10; -; 1. DR Gene3D; 3.50.30.30; -; 1. DR InterPro; IPR012341; 6hp_glycosidase-like_sf. DR InterPro; IPR044674; EDEM1/2/3. DR InterPro; IPR037322; EDEM3_PA. DR InterPro; IPR001382; Glyco_hydro_47. DR InterPro; IPR046450; PA_dom_sf. DR InterPro; IPR003137; PA_domain. DR InterPro; IPR036026; Seven-hairpin_glycosidases. DR PANTHER; PTHR45679; ER DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 2; 1. DR PANTHER; PTHR45679:SF2; ER DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 3; 1. DR Pfam; PF01532; Glyco_hydro_47; 1. DR Pfam; PF02225; PA; 1. DR PRINTS; PR00747; GLYHDRLASE47. DR SUPFAM; SSF52025; PA domain; 1. DR SUPFAM; SSF48225; Seven-hairpin glycosidases; 1. DR PROSITE; PS00014; ER_TARGET; 1. DR Genevisible; Q2HXL6; MM. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Glycoprotein; Hydrolase; Metal-binding; KW Reference proteome; Signal; Unfolded protein response. FT SIGNAL 1..42 FT /evidence="ECO:0000255" FT CHAIN 43..931 FT /note="ER degradation-enhancing alpha-mannosidase-like FT protein 3" FT /id="PRO_0000316958" FT DOMAIN 675..780 FT /note="PA" FT REGION 790..908 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 928..931 FT /note="Prevents secretion from ER" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10138" FT COMPBIAS 790..804 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 808..830 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 831..848 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 860..906 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 147 FT /note="Proton donor" FT /evidence="ECO:0000250" FT ACT_SITE 294 FT /evidence="ECO:0000250" FT ACT_SITE 388 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:P31723" FT ACT_SITE 406 FT /evidence="ECO:0000250" FT BINDING 492 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P32906" FT CARBOHYD 119 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 196 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 505 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 512 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 811 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 815 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 899 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT MUTAGEN 147 FT /note="E->Q: Loss of ERAD activity." FT /evidence="ECO:0000269|PubMed:16431915" FT CONFLICT 784 FT /note="E -> K (in Ref. 1; BAE79485)" FT /evidence="ECO:0000305" SQ SEQUENCE 931 AA; 104200 MW; 4F010D17E84E542C CRC64; MSKAGGCRGC GCRVPQRASW SLVAATAALC LVLATSVCTA GAAPMSREEK QKLGNQVLEM FDHAYGNYME HAYPADELMP LTCRGRVRGQ EPSRGDVDDA LGKFSLTLID SLDTLVVLNK TKEFEDAVRK VLRDVNLDND VVVSVFETNI RVLGGLLGGH SLAIMLKEKG EHMQWYNDEL LHMAKQLGYK LLPAFNTTSG LPYPRINLKF GIRKPEARTG TETDTCTACA GTLILEFAAL SRFTGATIFE EYARKALDFL WEKRQRSSNL VGVTINIHTG DWVRKDSGVG AGIDSYYEYL LKAYVLLGDD SFLERFNTHY DAIMRYISQP PLLLDVHIHK PMLNARTWMD ALLAFFPGLQ VLKGDIRPAI ETHEMLYQVI KKHNFLPEAF TTDFRVHWAQ HPLRPEFAES TYFLYKATGD PYYLEVGKTL IENLNKYARV PCGFAAMKDV RTGSHEDRMD SFFLAEMFKY LYLLFADKED IIFDIEDYIF TTEAHLLPLW LSTTNRSISK KNTTSEYTEL DDSNFDWTCP NTQILFPNDP LYAQSIREPL KNVVDKSCPR GIIRVEESFR SGAKPPLRAR DFMATNPEHL EILKKMGVSL IHLKDGRVQL VQHAIQAASS IDAEDGLRFM QEMIELSSQQ QKEQQLPPRA VQIISHPFFG RVVLTAGPAQ FGLDLSKHKE TRGFVASSKP YNGCSELTNP EAVMGKIALI QRGQCMFAEK ARNIQNAGAI GGIVIDDNEG SSSDTAPLFQ MAGDGKDTDD IKIPMLFLFS KEGSIILDAI REHEQVEVLL SDKARDRDPE MENEDQPSSE NDSQNQSAEQ MLSLSQTVDL ADKESPEHPA DSHSEASPSD SEEAAGFAPS EQISGSTENH ETTSLDGECT DLDNQVQEQS ETEEDSSPNV SWGTKAQPID SILADWNEDI EAFEMMEKDE L //